| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |